Cargando…

Antibiotic stewardship in skin infections: a cross-sectional analysis of early-career GP’s management of impetigo

OBJECTIVE: To establish the prevalence and associations of systemic antibiotic prescription for impetigo by early-career general practitioners (GPs) (GP registrars in their first 18 months in general practice). DESIGN: A cross-sectional analysis of data from the Registrar Clinical Encounters in Trai...

Descripción completa

Detalles Bibliográficos
Autores principales: Heal, Clare, Gorges, Hilary, van Driel, Mieke L, Tapley, Amanda, Davis, Josh, Davey, Andrew, Holliday, L, Ball, Jean, Najib, Nashwa, Spike, Neil, FitzGerald, Kristen, Magin, Parker
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830714/
https://www.ncbi.nlm.nih.gov/pubmed/31662391
http://dx.doi.org/10.1136/bmjopen-2019-031527
_version_ 1783465826357084160
author Heal, Clare
Gorges, Hilary
van Driel, Mieke L
Tapley, Amanda
Davis, Josh
Davey, Andrew
Holliday, L
Ball, Jean
Najib, Nashwa
Spike, Neil
FitzGerald, Kristen
Magin, Parker
author_facet Heal, Clare
Gorges, Hilary
van Driel, Mieke L
Tapley, Amanda
Davis, Josh
Davey, Andrew
Holliday, L
Ball, Jean
Najib, Nashwa
Spike, Neil
FitzGerald, Kristen
Magin, Parker
author_sort Heal, Clare
collection PubMed
description OBJECTIVE: To establish the prevalence and associations of systemic antibiotic prescription for impetigo by early-career general practitioners (GPs) (GP registrars in their first 18 months in general practice). DESIGN: A cross-sectional analysis of data from the Registrar Clinical Encounters in Training (ReCEnT) study. SETTING: ReCEnT is an ongoing multisite cohort study of Australian registrars’ in-consultation clinical practice across five Australian states. PARTICIPANTS: Registrars participating in ReCEnT from 2010 to 2017. OUTCOME MEASURES: Management of impetigo with systemic antibiotics. RESULTS: 1741 registrars (response rate 96%) provided data from 384 731 problems identified in 246 434 consultations. Impetigo, on first presentation or follow-up, was managed in 930 (0.38%, 95% CI 0.35 to 0.40) consultations and comprised 0.24% (95% CI 0.23 to 0.26) of problems. 683 patients presented with a new diagnosis of impetigo of which 38/683 (5.6%) were not prescribed antibiotics; 239/683 (35.0%) were prescribed solely topical antibiotics; 306/683 (44.8%) solely systemic antibiotics and 100/683 (14.6%) both systemic and topical antibiotics. The most common systemic antibiotic prescribed was cephalexin (53.5%). Variables independently associated with prescription of systemic antibiotics were an inner regional (compared with major city) location (OR 1.82, 95% CI 1.06 to 3.13; p=0.028), seeking in-consultation information or advice (OR 2.17, 95% CI 1.47 to 3.23; p<0.001) and ordering pathology (OR 2.13, 95% CI 1.37 to 3.33; p=0.01). CONCLUSIONS: Australian early-career GPs prescribe systemic antibiotics (the majority broad-spectrum) for a high proportion of initial impetigo presentations. Impetigo guidelines should clearly specify criteria for systemic antibiotic prescription and individual antibiotic choice. The role of non-antibiotic management and topical antiseptics needs to be explored further.
format Online
Article
Text
id pubmed-6830714
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-68307142019-11-20 Antibiotic stewardship in skin infections: a cross-sectional analysis of early-career GP’s management of impetigo Heal, Clare Gorges, Hilary van Driel, Mieke L Tapley, Amanda Davis, Josh Davey, Andrew Holliday, L Ball, Jean Najib, Nashwa Spike, Neil FitzGerald, Kristen Magin, Parker BMJ Open Infectious Diseases OBJECTIVE: To establish the prevalence and associations of systemic antibiotic prescription for impetigo by early-career general practitioners (GPs) (GP registrars in their first 18 months in general practice). DESIGN: A cross-sectional analysis of data from the Registrar Clinical Encounters in Training (ReCEnT) study. SETTING: ReCEnT is an ongoing multisite cohort study of Australian registrars’ in-consultation clinical practice across five Australian states. PARTICIPANTS: Registrars participating in ReCEnT from 2010 to 2017. OUTCOME MEASURES: Management of impetigo with systemic antibiotics. RESULTS: 1741 registrars (response rate 96%) provided data from 384 731 problems identified in 246 434 consultations. Impetigo, on first presentation or follow-up, was managed in 930 (0.38%, 95% CI 0.35 to 0.40) consultations and comprised 0.24% (95% CI 0.23 to 0.26) of problems. 683 patients presented with a new diagnosis of impetigo of which 38/683 (5.6%) were not prescribed antibiotics; 239/683 (35.0%) were prescribed solely topical antibiotics; 306/683 (44.8%) solely systemic antibiotics and 100/683 (14.6%) both systemic and topical antibiotics. The most common systemic antibiotic prescribed was cephalexin (53.5%). Variables independently associated with prescription of systemic antibiotics were an inner regional (compared with major city) location (OR 1.82, 95% CI 1.06 to 3.13; p=0.028), seeking in-consultation information or advice (OR 2.17, 95% CI 1.47 to 3.23; p<0.001) and ordering pathology (OR 2.13, 95% CI 1.37 to 3.33; p=0.01). CONCLUSIONS: Australian early-career GPs prescribe systemic antibiotics (the majority broad-spectrum) for a high proportion of initial impetigo presentations. Impetigo guidelines should clearly specify criteria for systemic antibiotic prescription and individual antibiotic choice. The role of non-antibiotic management and topical antiseptics needs to be explored further. BMJ Publishing Group 2019-10-28 /pmc/articles/PMC6830714/ /pubmed/31662391 http://dx.doi.org/10.1136/bmjopen-2019-031527 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Infectious Diseases
Heal, Clare
Gorges, Hilary
van Driel, Mieke L
Tapley, Amanda
Davis, Josh
Davey, Andrew
Holliday, L
Ball, Jean
Najib, Nashwa
Spike, Neil
FitzGerald, Kristen
Magin, Parker
Antibiotic stewardship in skin infections: a cross-sectional analysis of early-career GP’s management of impetigo
title Antibiotic stewardship in skin infections: a cross-sectional analysis of early-career GP’s management of impetigo
title_full Antibiotic stewardship in skin infections: a cross-sectional analysis of early-career GP’s management of impetigo
title_fullStr Antibiotic stewardship in skin infections: a cross-sectional analysis of early-career GP’s management of impetigo
title_full_unstemmed Antibiotic stewardship in skin infections: a cross-sectional analysis of early-career GP’s management of impetigo
title_short Antibiotic stewardship in skin infections: a cross-sectional analysis of early-career GP’s management of impetigo
title_sort antibiotic stewardship in skin infections: a cross-sectional analysis of early-career gp’s management of impetigo
topic Infectious Diseases
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830714/
https://www.ncbi.nlm.nih.gov/pubmed/31662391
http://dx.doi.org/10.1136/bmjopen-2019-031527
work_keys_str_mv AT healclare antibioticstewardshipinskininfectionsacrosssectionalanalysisofearlycareergpsmanagementofimpetigo
AT gorgeshilary antibioticstewardshipinskininfectionsacrosssectionalanalysisofearlycareergpsmanagementofimpetigo
AT vandrielmiekel antibioticstewardshipinskininfectionsacrosssectionalanalysisofearlycareergpsmanagementofimpetigo
AT tapleyamanda antibioticstewardshipinskininfectionsacrosssectionalanalysisofearlycareergpsmanagementofimpetigo
AT davisjosh antibioticstewardshipinskininfectionsacrosssectionalanalysisofearlycareergpsmanagementofimpetigo
AT daveyandrew antibioticstewardshipinskininfectionsacrosssectionalanalysisofearlycareergpsmanagementofimpetigo
AT hollidayl antibioticstewardshipinskininfectionsacrosssectionalanalysisofearlycareergpsmanagementofimpetigo
AT balljean antibioticstewardshipinskininfectionsacrosssectionalanalysisofearlycareergpsmanagementofimpetigo
AT najibnashwa antibioticstewardshipinskininfectionsacrosssectionalanalysisofearlycareergpsmanagementofimpetigo
AT spikeneil antibioticstewardshipinskininfectionsacrosssectionalanalysisofearlycareergpsmanagementofimpetigo
AT fitzgeraldkristen antibioticstewardshipinskininfectionsacrosssectionalanalysisofearlycareergpsmanagementofimpetigo
AT maginparker antibioticstewardshipinskininfectionsacrosssectionalanalysisofearlycareergpsmanagementofimpetigo